原发性肝癌介入术后并发症治疗临床观察  

The clinical observation of treatment of complications after intervention operation of hepatic carcinoma

作　　者：杨潇瑾[1] 张振纲[1] 杨道锋[1] 宁琴[1] 吴迪[1] 

机构地区：[1]华中科技大学同济医学院附属同济医院感染科 华中科技大学同济医学院附属同济医院感染性疾病研究所,湖北武汉430030

出　　处：《中国医药科学》2013年第13期20-21,88,共3页China Medicine And Pharmacy

摘　　要：目的评价对症治疗在原发性肝癌介入术后患者临床恢复期疗效。方法回顾分析在我院感染科,原发性肝癌患者行介入术后86例患者,临床恢复期内,使用常规对症疗法治疗术后并发症的疗效。结果患者在肝癌介入术后一般对症疗法,无特殊不良反应。结论一般性对症支持疗法缓解肝癌介入术后患者术后不良反应有较好的疗效和治疗安全性。Objective To assess the clinical value of symptomatic treatment in the convalescent of hepatic carcinoma patients who received intervention operation. Methods Made a retrospective analysis into 86 hepatic carcinoma patients in the department of infectious disease in our hospital,we observed the effects of routine symptomatic treatment on the convalescent after intervention operation. Results There were no adverse reactions of routine symptomatic treatment in the treatment of complications after intervention operation. Conclusion Routine symptomatic treatment can effectively and safely alleviate the adverse reactions of hepatic carcinoma patients after intervention operation.

关 键 词：原发性肝癌 介入手术 术后并发症 治疗 

分 类 号：R735.7[医药卫生—肿瘤]